A shift toward activated Treg subtypes was seen in patients with COVID-19 with increases in the activated CCR4+ (annotated as CCR4+), Helios–CCR6+ effectors, and several groups of proliferating Tregs (Fig. 3 C–E). The gene discussed is CCR6; the disease is COVID-19.